Evidence map›Paper›PMID 30626963›Full record

ArticleNature protocols2019

Systemic AAV vectors for widespread and targeted gene delivery in rodents.

Rosemary C Challis, Sripriya Ravindra Kumar, Ken Y Chan, Collin Challis, Keith Beadle, Min J Jang, Hyun Min Kim, Pradeep S Rajendran, John D Tompkins, Kalyanam Shivkumar and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Nature protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 295 papers.

0numbers the graph read from it
0cells of the map it votes in
295citing papers in PubMed
29.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

295 citing papers in PubMed, 417 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Priming of CD8Nature neuroscience · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Structural basis of liver de-targeting and neuronal tropism of CNS-targeted AAV capsids.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  19. Article
  20. Article

235 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Rosemary C ChallisDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Sripriya Ravindra KumarDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Ken Y ChanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Collin ChallisDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Keith BeadleDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Min J JangDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Hyun Min KimDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Pradeep S RajendranCardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9790-0408
John D TompkinsCardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, Los Angeles, CA, USA.
Kalyanam ShivkumarCardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, Los Angeles, CA, USA.
Benjamin E DevermanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Viviana GradinaruDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. viviana@caltech.edu.ORCID http://orcid.org/0000-0001-5868-348X
California Institute of Technology · USUniversity of California, Los Angeles · US

Funding

Comprehensive Structural and Functional Mapping of the Mammalian Cardiac Nervous SystemOT2OD023848 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EFIMOV, IGOR R, FOWLKES, CHARLESS · 2016 to 2021
$21.4M
Neuromodulation and Neurodegeneration: the Missing Link and Mechanisms of ActionDP2NS087949 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GRADINARU, VIVIANA · 2013 to 2019
$4.1M
Time-Reversal Optical Focusing for Noninvasive OptogeneticsU01NS090577 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GRADINARU, VIVIANA, YANG, CHANGHUEI · 2014 to 2016
$2.0M
Intact Circuit Assessment of Aging Dopamine Neurons vis Optogenetics and CLARITYR01AG047664 · NIA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GRADINARU, VIVIANA · 2014 to 2018
$2.0M
NIA NIH HHS R01 AG047664NIH HHS OT2 OD023848NINDS NIH HHS DP2 NS087949NINDS NIH HHS U01 NS090577
6 · The paper itself

Abstract

We recently developed adeno-associated virus (AAV) capsids to facilitate efficient and noninvasive gene transfer to the central and peripheral nervous systems. However, a detailed protocol for generating and systemically delivering novel AAV variants was not previously available. In this protocol, we describe how to produce and intravenously administer AAVs to adult mice to specifically label and/or genetically manipulate cells in the nervous system and organs, including the heart. The procedure comprises three separate stages: AAV production, intravenous delivery, and evaluation of transgene expression. The protocol spans 8 d, excluding the time required to assess gene expression, and can be readily adopted by researchers with basic molecular biology, cell culture, and animal work experience. We provide guidelines for experimental design and choice of the capsid, cargo, and viral dose appropriate for the experimental aims. The procedures outlined here are adaptable to diverse biomedical applications, from anatomical and functional mapping to gene expression, silencing, and editing.

Indexed as

Gene Transfer TechniquesAnimalsBrainCapsidDependovirusGastrointestinal TractGenes, ReporterGenetic TherapyGenetic VectorsGreen Fluorescent ProteinsHEK293 CellsHumansInjections, IntravenousLuminescent ProteinsMiceMyocardiumGreen Fluorescent ProteinsLuminescent ProteinsRed Fluorescent Protein

Identifiers

PMID30626963
PMCPMC13333184
OpenAlexW2910480910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.